1. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA;
2. Department of Medicine, Hematology and Oncology, Universitätsklinikum Münster, Münster, Germany;
3. Department of Hematology/Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA;
4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;
5. Department of Medicine II, University Hospital, Goethe University, Frankfurt, Germany;
6. Bristol Haematology & Oncology Centre, University Hospitals Bristol NHS Trust, Bristol, UK;
7. Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA;
8. Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA, USA;
9. Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA;
10. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;
11. Global Product Development – Oncology, Pfizer Inc, Cambridge, MA, USA;
12. Pfizer Pharma GmbH, Berlin, Germany